• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PROPLEX与PROPLEX SX对比:一项针对患有VIII因子抑制剂的A型血友病患者急性关节积血治疗效果的对照双盲研究。

PROPLEX vs. PROPLEX SX: a controlled double blind study of the effectiveness in treating acute hemarthroses in hemophilia A patients with inhibitors to factor VIII.

作者信息

Gomperts E D, Fannon R B, Lee M L, Kingdon H S, Kantrowitz J L, Addiego J E, Carney J, Corrigan J J, Hathaway W, Hilgartner M W

出版信息

Thromb Res. 1986 Jun 15;42(6):789-96. doi: 10.1016/0049-3848(86)90115-5.

DOI:10.1016/0049-3848(86)90115-5
PMID:3726800
Abstract

A blinded randomized multicenter trial of two non-activated prothrombin complex concentrates was carried out to determine the clinical effectivity in the treatment of acute hemarthrosis in hemophiliac patients with inhibitors. The one product was prepared via DEAE Sephadex chromatography, while the second was fractionated via various precipitation procedures including polyethylene glycol. Equivalence of the two products was established with less than 15% difference in efficacy rates.

摘要

开展了一项针对两种未激活凝血酶原复合物浓缩剂的双盲随机多中心试验,以确定其在治疗患有抑制剂的血友病患者急性关节积血方面的临床有效性。一种产品通过二乙氨基乙基葡聚糖凝胶色谱法制备,而另一种则通过包括聚乙二醇在内的各种沉淀程序进行分级分离。两种产品的等效性得以确立,有效率差异小于15%。

相似文献

1
PROPLEX vs. PROPLEX SX: a controlled double blind study of the effectiveness in treating acute hemarthroses in hemophilia A patients with inhibitors to factor VIII.PROPLEX与PROPLEX SX对比:一项针对患有VIII因子抑制剂的A型血友病患者急性关节积血治疗效果的对照双盲研究。
Thromb Res. 1986 Jun 15;42(6):789-96. doi: 10.1016/0049-3848(86)90115-5.
2
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII.自体凝血酶原复合物与凝血酶原复合物:一项针对血友病伴Ⅷ因子抑制物患者急性关节积血疗效的对照双盲研究。
Blood. 1983 Nov;62(5):1135-8.
3
Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.凝血酶原复合物浓缩剂在伴有抗凝血因子VIII抗体的血友病患者中的疗效:一项多中心治疗试验。
N Engl J Med. 1980 Aug 21;303(8):421-5. doi: 10.1056/NEJM198008213030803.
4
Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
JAMA. 1976 Nov 1;236(18):2061-4. doi: 10.1001/jama.236.18.2061.
5
The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitors.凝血酶原复合物浓缩剂在治疗伴有VIII因子抑制剂的血友病患者中的作用。
Scand J Haematol Suppl. 1984;40:195-202. doi: 10.1111/j.1600-0609.1984.tb02564.x.
6
Treatment of hemophilia.血友病的治疗。
Ric Clin Lab. 1985 Oct-Dec;15(4):289-303.
7
[Substitution therapy of hemorrhagic diseases].[出血性疾病的替代疗法]
Anasthesiol Intensivmed Prax. 1975 Oct;11(1):137-44.
8
A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
Thromb Haemost. 1980 Aug 29;44(1):39-42.
9
Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
J Pediatr. 1976 Feb;88(2):200-5. doi: 10.1016/s0022-3476(76)80982-1.
10
Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.凝血酶原复合物浓缩剂在有抑制剂的血友病患者中的应用:临床和实验室研究。
Pediatrics. 1978 Nov;62(5):767-74.